TY - JOUR
T1 - Cognitive deficit in methamphetamine users relative to childhood academic performance
T2 - Link to cortical thickness
AU - Dean, Andy C.
AU - Morales, Angelica M.
AU - Hellemann, Gerhard
AU - London, Edythe D.
N1 - Funding Information:
This research was supported by NIH grants K23 DA027734 (A.C.D.), R21 DA034928 (A. C.D.), P20 DA022539 (E.D.L.), R01 DA020726 (E.D.L.), M01 RR00865 (UCLA GCRC), UL1TR000124 (UCLA CTSI), and endowments from the Thomas P and Katherine K Pike Chair in Addiction Studies and the Marjorie M Greene Trust (E.D.L.)
Funding Information:
We gratefully acknowledge the efforts of several graduate students and researchers who worked with study participants or research data, with whom this work would not have been possible: Ahoo Karimian, Psy.D; Alexandria Davis, MPA; Brittany Reid, Psy. D; Dara Ghahremani, Ph.D.; Edmon Artinyan, M.A.; Eric Wagreich; M.D.; Eugene Oh; Hannah Jones, Ph.D; Kimberly Lin; Kimberly Price; Kristina Mouzakis; Lori Meono, Psy. D; Maritza Johnson; Meredith Blackburn, M.A.; Milky Kohno, PhD; Sarah Klein, M.A.; and Thomas Hanson, Psy.D. We also thank Robert Bilder, Ph.D and Russel Poldrack, Ph.D for their helpful comments on the associated grant application. This research was supported by NIH grants K23 DA027734 (A.C.D.), R21 DA034928 (A. C.D.), P20 DA022539 (E.D.L.), R01 DA020726 (E.D.L.), M01 RR00865 (UCLA GCRC), UL1TR000124 (UCLA CTSI), and endowments from the Thomas P and Katherine K Pike Chair in Addiction Studies and the Marjorie M Greene Trust (E.D.L.)
Publisher Copyright:
© 2018 American College of Neuropsychopharmacology.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Individuals with cognitive problems may be predisposed to develop substance use disorders; therefore, differences in cognitive function between methamphetamine users and control participants may be attributable to premorbid factors rather than methamphetamine use. The goal of this study was to clarify the extent to which this is the case. Childhood academic transcripts were obtained for 37 methamphetamine-dependent adults and 41 control participants of similar educational level and premorbid IQ. Each participant completed a comprehensive cognitive battery and received a structural magnetic resonance imaging scan. Data from control participants and linear regression were used to develop a normative model to describe the relationship between childhood academic performance and scores on the cognitive battery. Using this model, cognitive performance of methamphetamine users was predicted from their premorbid academic scores. Results indicated that methamphetamine users' childhood grade point average was significantly lower than that of the control group (p < 0.05). Further, methamphetamine users' overall cognitive performance was lower than was predicted from their grade point average prior to methamphetamine use (p = 0.001), with specific deficits in attention/concentration and memory (ps < 0.01). Memory deficits were associated with lower whole-brain cortical thickness (p < 0.05). Thus, in addition to having an apparent premorbid weakness in cognition, methamphetamine users exhibit subsequent cognitive function that is significantly lower than premorbid estimates would predict. The results support the view that chronic methamphetamine use causes a decline in cognition and/or a failure to develop normative cognitive abilities, although aside from methamphetamine use per se, other drug use and unidentified factors likely contribute to the observed effects.
AB - Individuals with cognitive problems may be predisposed to develop substance use disorders; therefore, differences in cognitive function between methamphetamine users and control participants may be attributable to premorbid factors rather than methamphetamine use. The goal of this study was to clarify the extent to which this is the case. Childhood academic transcripts were obtained for 37 methamphetamine-dependent adults and 41 control participants of similar educational level and premorbid IQ. Each participant completed a comprehensive cognitive battery and received a structural magnetic resonance imaging scan. Data from control participants and linear regression were used to develop a normative model to describe the relationship between childhood academic performance and scores on the cognitive battery. Using this model, cognitive performance of methamphetamine users was predicted from their premorbid academic scores. Results indicated that methamphetamine users' childhood grade point average was significantly lower than that of the control group (p < 0.05). Further, methamphetamine users' overall cognitive performance was lower than was predicted from their grade point average prior to methamphetamine use (p = 0.001), with specific deficits in attention/concentration and memory (ps < 0.01). Memory deficits were associated with lower whole-brain cortical thickness (p < 0.05). Thus, in addition to having an apparent premorbid weakness in cognition, methamphetamine users exhibit subsequent cognitive function that is significantly lower than premorbid estimates would predict. The results support the view that chronic methamphetamine use causes a decline in cognition and/or a failure to develop normative cognitive abilities, although aside from methamphetamine use per se, other drug use and unidentified factors likely contribute to the observed effects.
UR - http://www.scopus.com/inward/record.url?scp=85046012668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046012668&partnerID=8YFLogxK
U2 - 10.1038/s41386-018-0065-1
DO - 10.1038/s41386-018-0065-1
M3 - Article
C2 - 29704001
AN - SCOPUS:85046012668
SN - 0893-133X
VL - 43
SP - 1745
EP - 1752
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 8
ER -